Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Ford

Showing results (111-120 of 156) with videos related to

Pageof 16
Sort By:
European Heart Journal|November 1, 1994
Cardiorespiratory and symptomatic variables during maximal and submaximal exercise in men with stable effort angina: a comparison of atenolol and celiprololS G Ray, G McCann, E Henderson, et al.
Occupational and Environmental Medicine|November 20, 2008
A panel study of air pollution in subjects with heart failure: negative results in treated patientsJ L Barclay, B G Miller, S Dick, et al.
Cerebrovascular Diseases (Basel, Switzerland)|May 2, 2009
The Prevention of cerebrovascular and cardiovascular Events of ischemic origin with teRutroban in patients with a history oF ischemic strOke or tRansient ischeMic attack (PERFORM) study: baseline characteristics of the populationM G Bousser, P Amarenco, A Chamorro, et al.
Acta Neurochirurgica. Supplementum|January 1, 1993
Quantification of primary and secondary lesions in severe head injuryD I Graham, J H Adams, D Doyle, et al.
Cerebrovascular Diseases (Basel, Switzerland)|April 18, 2009
Rationale and design of a randomized, double-blind, parallel-group study of terutroban 30 mg/day versus aspirin 100 mg/day in stroke patients: the prevention of cerebrovascular and cardiovascular events of ischemic origin with terutroban in patients with a history of ischemic stroke or transient ischemic attack (PERFORM) studyM G Bousser, P Amarenco, A Chamorro, et al.
British Heart Journal|November 1, 1990
Novel exercise protocol suitable for use on a treadmill or a bicycle ergometerD B Northridge, S Grant, I Ford, et al.
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|October 1, 1995
The South African Pilot Hospital Accreditation ProgrammeM Muller, P van den Berg, I Ford, et al.
The New England Journal of Medicine|November 16, 1995
Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study GroupJ Shepherd, S M Cobbe, I Ford, et al.
Heart (British Cardiac Society)|April 15, 2006
Economic evaluation of the impact of nicorandil in angina (IONA) trialA Walker, J McMurray, S Stewart, et al.
Heart (British Cardiac Society)|February 21, 1998
Brain natriuretic peptide is stable in whole blood and can be measured using a simple rapid assay: implications for clinical practiceD R Murdoch, J Byrne, J J Morton, et al.
Pageof 16

Showing results (111-120 of 156) with videos related to

Sort By:
Pageof 16
European Heart Journal|November 1, 1994
Cardiorespiratory and symptomatic variables during maximal and submaximal exercise in men with stable effort angina: a comparison of atenolol and celiprololS G Ray, G McCann, E Henderson, et al.
Occupational and Environmental Medicine|November 20, 2008
A panel study of air pollution in subjects with heart failure: negative results in treated patientsJ L Barclay, B G Miller, S Dick, et al.
Cerebrovascular Diseases (Basel, Switzerland)|May 2, 2009
The Prevention of cerebrovascular and cardiovascular Events of ischemic origin with teRutroban in patients with a history oF ischemic strOke or tRansient ischeMic attack (PERFORM) study: baseline characteristics of the populationM G Bousser, P Amarenco, A Chamorro, et al.
Acta Neurochirurgica. Supplementum|January 1, 1993
Quantification of primary and secondary lesions in severe head injuryD I Graham, J H Adams, D Doyle, et al.
Cerebrovascular Diseases (Basel, Switzerland)|April 18, 2009
Rationale and design of a randomized, double-blind, parallel-group study of terutroban 30 mg/day versus aspirin 100 mg/day in stroke patients: the prevention of cerebrovascular and cardiovascular events of ischemic origin with terutroban in patients with a history of ischemic stroke or transient ischemic attack (PERFORM) studyM G Bousser, P Amarenco, A Chamorro, et al.
British Heart Journal|November 1, 1990
Novel exercise protocol suitable for use on a treadmill or a bicycle ergometerD B Northridge, S Grant, I Ford, et al.
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|October 1, 1995
The South African Pilot Hospital Accreditation ProgrammeM Muller, P van den Berg, I Ford, et al.
The New England Journal of Medicine|November 16, 1995
Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study GroupJ Shepherd, S M Cobbe, I Ford, et al.
Heart (British Cardiac Society)|April 15, 2006
Economic evaluation of the impact of nicorandil in angina (IONA) trialA Walker, J McMurray, S Stewart, et al.
Heart (British Cardiac Society)|February 21, 1998
Brain natriuretic peptide is stable in whole blood and can be measured using a simple rapid assay: implications for clinical practiceD R Murdoch, J Byrne, J J Morton, et al.
Pageof 16